Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012

Size: px
Start display at page:

Download "Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012"

Transcription

1 Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH

2 RICHARD FRIEDLAND GROUP CEO Group overview South Africa United Kingdom KEITH GIBSON GROUP CFO Financial review Guidance Agenda 2

3 Group overview 3

4 Group overview South Africa (SA) Ongoing efficiencies have enhanced performance Dedicated focus on quality care yielded improved outcomes across all divisions NHI: all hospitals completed DOH* core standards and Primary Care well positioned Innovative integrated health model in Lesotho PPP fully operational United Kingdom (UK) Good performance in challenging economic environment Now the largest independent hospital provider to NHS Choose and Book Focus on core business and driving efficiencies i i Continued focus on Oct 2013 maturity of non-recourse PropCo debt * Department of Health CARE DIGNITY TRUTH PARTICIPATION PASSION 4

5 Group financial overview Revenue R12 654m 11.1% EBITDA R2 477m 9.3% Profit before taxation R870m 15.5% Adjusted HEPS 51.9 cps 16.1% CARE DIGNITY TRUTH PARTICIPATION PASSION 5

6 South Africa 6

7 A comprehensive network of healthcare services 2012 EBITDA margin² Hospitals 51 PPP hospitals¹ 5 Primary health facilities % 17.2% 18.7% 19.6% Dialysis units 56 Emergency vehicles 182 Pharmacies 85 Registered beds Employees¹ H H H H Includes SA and Lesotho 2. Before intergroup rental charge CARE DIGNITY TRUTH PARTICIPATION PASSION 7

8 South Africa Rm % Revenue EBITDA¹ Operating profit¹ EBITDA margin (%) Operating profit margin (%) Weighted average revenue growth across all service lines 13.0% in EBITDA and 90 bps in EBITDA margin due to continuing operating leverage Winner of healthcare sector FM s Top Empowerment Companies 2012 for 4th consecutive year² 1. Before capital charges 2. Source: Financial Mail, April CARE DIGNITY TRUTH PARTICIPATION PASSION 8

9 SA Hospitals and Emergency services Rm % Netcare Hospital division has the Revenue highest complexity network 91 beds added in H EBITDA¹ % in patient days 5.6% gross revenue per Operating profit¹ patient day 45%-50% of revenue now ARM² EBITDA margin (%) Operating profit margin (%) EBITDA margin expansion due to continuing operating leverage Note: EBITDA and operating profit are reflected before rental charges from Netcare property companies. 41 hospital properties, which have been independently valued at R12.4bn, are owned by designated property companies Margins diluted by: 48 retail pharmacies 56 renal centres (621 dialysis stations)³ Netcare 911 Waterfall rental (OpCo only) 1. Before capital charges 2. Alternative Reimbursement Methodology (DRG/capitation/per p diems/fixed fees) 3. 50% ownership of National Renal Care CARE DIGNITY TRUTH PARTICIPATION PASSION 9

10 Primary Care Rm % Revenue EBITDA* Operating profit* EBITDA margin (%) Operating profit margin (%) >1.5 million patient visits > managed care lives > scripts, 9.5% EBITDA growth and margin improvement due to: continuing efficiencies better risk profile * Before capital charges CARE DIGNITY TRUTH PARTICIPATION PASSION 10

11 Primary Care: continued improvement EBITDA* (Rm) 45 Medicross and Prime Cure comprise the largest private national network of GP group practices with 557 doctors and dentists Primary care increasingly more important in the delivery of sustainable and affordable healthcare -20 (16) H H H H Prime Cure well positioned as medical scheme contribution tax credits which could stimulate low income membership * Before capital charges CARE DIGNITY TRUTH PARTICIPATION PASSION 11

12 Significant improvement in quality KPIs October 2011 Better than expected On target Less than expected Prevention of Healthcare Associated Infections Ventilator Associated Pneumonia (VAP) Surgical Site Infection (SSI) Central Line Associated Blood Stream Infection (CLABSI) Catheter Associated Urinary Tract Infections (CAUTI) Antibiotic stewardship Optimising care in Acute Myocardial Infarction (AMI) Prevention of Deep Vein Thrombosis (DVT)* Benchmarking outcomes in neonatal intensive care to the Vermont Oxford Network Elevating cardiopulmonary resuscitation response Netcare 911: monitoring helicopter emergency service outcomes* Netcare 911: monitoring fixed wing emergency service outcomes* National Renal Care: international benchmarks of dialysis outcomes* * Unique to Netcare CARE DIGNITY TRUTH PARTICIPATION PASSION 12

13 Significant improvement in quality KPIs Enhanced performance over 6 months March 2012 Better than expected On target Less than expected Prevention of Healthcare Associated Infections Ventilator Associated Pneumonia (VAP) Surgical Site Infection (SSI) Central Line Associated Blood Stream Infection (CLABSI) Catheter Associated Urinary Tract Infections (CAUTI) Antibiotic stewardship Optimising care in Acute Myocardial Infarction (AMI) Prevention of Deep Vein Thrombosis (DVT)* Benchmarking outcomes in neonatal intensive care to the Vermont Oxford Network Elevating cardiopulmonary resuscitation response Netcare 911: monitoring helicopter emergency service outcomes* Netcare 911: monitoring fixed wing emergency service outcomes* National Renal Care: international benchmarks of dialysis outcomes* * Unique to Netcare CARE DIGNITY TRUTH PARTICIPATION PASSION 13

14 Health reform NHI pilots a significant move forward White paper imminent In preparation for NHI, all hospitals completed National DOH¹ core standards assessment Inflation² Netcare s diversified health services well poised for partnership on NHI delivery Competition Commission may probe private healthcare; final decision pending Hospital price inflation well contained Petrol Water Electricity Medical Hospital insurance Department of Health 2. Source: Stats SA CARE DIGNITY TRUTH PARTICIPATION PASSION 14

15 Focus areas over the next 18 months Concerted focus on shared services including SAP rollout completion in mid 2013 Procurement efficiencies through standardisation of product portfolio Integrating 85 Hospital and Medicross pharmacy operations into a national offering Brownfield expansion projects: H2 2012: 68 beds 2013: 117 beds Enhancing capacity utilisation in hospitals and expanding oncology offering Driving enhanced patient service levels and quality care: the Netcare Way Implementation of energy saving initiatives from the last quarter of 2012 CARE DIGNITY TRUTH PARTICIPATION PASSION 15

16 United Kingdom 16

17 Business overview Macro economic environment remains very challenging Continued recovery in Self-pay and strong NHS demand Decline in private medical insurance (PMI) beginning to slow EBITDA margin impacted by payor mix Strong working capital management and record cash of 123m Senior management team further strengthened CARE DIGNITY TRUTH PARTICIPATION PASSION 17

18 UK income statement m % Revenue EBITDA before items below (1.7) Profit on disposal of property 4.4 Other non-recurring items (4.3) (4.1) Reported EBITDA (6.1) EBITDA margin (%) Reported EBITDA margin (%) % in inpatient and day case admissions EBITDA impacted by increased mix of NHS vs. private patients EBITDA margin a blend of: Owned hospitals, 22.3% margin Leased and managed hospitals (acquired for nominal cash outlay), 17.8% margin Care and Transform CARE DIGNITY TRUTH PARTICIPATION PASSION 18

19 UK income statement: H1 segmental analysis m OpCo PropCo Consolidation journals WholeCo Revenue (66.7) EBITDAR (66.7) 98.9 Rentals - External (10.2) (10.2) - Internal (66.7) 66.7 EBITDA Depreciation and amortisation (21.7) (13.3) (35.0) Operating profit Net interest paid (7.9) (55.0) (62.9) Swap fair value adjustments (0.3) (7.0) (7.3) Loss before taxation (7.7) 7) (8.8) 8) (16.5) Taxation 14.2 Loss after taxation (2.3) CARE DIGNITY TRUTH PARTICIPATION PASSION 19

20 Funder mix continues to be impacted by economy Caseload* 18.0% in NHS cases NHS represents 27.3% of overall caseload (2011: 23.7%) Largest independent provider under Choose and Book 7.8% in Self-pay cases Self-pay continues to recover off a low base driven by NHS waiting lists 4.8% in PMI cases H H H H Insured Self-pay NHS * Excludes Transform and Abbey CARE DIGNITY TRUTH PARTICIPATION PASSION 20

21 UK health reform Patient Choice introduced in 2007 now entrenched As a result, private sector playing an increasing role in the delivery of public health Fiscal constraints in UK impacting on NHS delivery, creating opportunity for independent sector NHS 20bn productivity improvement challenge remains Health & Social Care Act passed in March 2012 Structural reorganisation under way within NHS Competition Commission to investigate healthcare; spans providers and funders CARE DIGNITY TRUTH PARTICIPATION PASSION 21

22 Financial review 22

23 Factors influencing results Exchange rate Average exchange rate of R12.42 (2011: R11.02) Closing rate of R12.25 (March 2011: R10.85; September 2011: R12.54) Interest rate swaps Ineffective portion of UK interest rate swaps: non-cash flow charge of R100m ( 8.1 m) (2011: R60m ( 5.4m)) Prior year UK property sale Sale of BMI Duchy Hospital (Harrogate) in January 2011, resulting in a R47m ( 4.4m) capital profit Taxation STC charge of R47m in SA; no STC in 2011 Reduction in UK statutory tax rate of 1% (2011: 1%) Benefit of non-cash deferred tax release of R163m ( 13.6m) (2011: R155m ( 14.0m)) CARE DIGNITY TRUTH PARTICIPATION PASSION 23

24 Summarised Group income statement Rm % Growth in both geographies Revenue EBITDA Operating profit Net financial expenses (948) (973) (2.6) Attributable t bl earnings of associates Profit before taxation Taxation (54) (164) (203.7) Profit for the period % SA Lower UK results softened by currency impact 2011 R47m profit on sale of UK property 44.5% SA 2.1m UK cash interest Swap ineffectiveness of R100m (2011: R60m) STC of R47m UK tax rate reduction of R163m (2011: R155m) CARE DIGNITY TRUTH PARTICIPATION PASSION 24

25 Constant currency yperformance Revenue Operating profit Net interest expense SA UK Exchange rate CARE DIGNITY TRUTH PARTICIPATION PASSION 25

26 Headline earnings per share Headline earnings per share (cents) Cents per share Headline earnings per share % Adjusted* headline earnings per share SA UK (1.6) (2.9) (81.3) H H H * Adjusted to exclude, inter alia, ineffective portion of interest rate swaps, fair value adjustments and UK tax rate change CARE DIGNITY TRUTH PARTICIPATION PASSION 26

27 Summarised statement of financial position Rm 31 Sep Forex effect Movement Assets PPE*, goodwill and intangible assets (808) (94) Other non-current assets (99) 428 Current assets (83) 298 Total assets (990) 632 Equity and liabilities Total shareholders equity (276) 485 Borrowings (553) 635 Other liabilities (161) (488) Total equity and liabilities (990) 632 Acquisition of economic interest in UK OpCo debt Deferred tax liability R4 871m (Sep 2011: R5 178m) Swap liability R5 309m (Sep 2011: R5 319m) * Property, plant and equipment CARE DIGNITY TRUTH PARTICIPATION PASSION 27

28 Movement in Group PPE* and intangible assets Rm (659) (12) (808) Sep 2011 Additions Depreciation Disposals Exchange rate Mar 2012 and amortisation and other impact * Property, plant and equipment CARE DIGNITY TRUTH PARTICIPATION PASSION 28

29 Acquisition of economic interest in UK OpCo debt Key figures m Rm Face value Cash outlay Discount on purchase of interest H H2 (estimate) * Pre-taxation earnings impact Total OpCo gross debt 230.5m 29.7% discount to face value Economic benefit to Netcare to be recognised in financial income over remaining OpCo debt term ( ) Interest income is also earned * Based on average exchange rate applicable to H CARE DIGNITY TRUTH PARTICIPATION PASSION 29

30 Group borrowings at ch 2012 Gross borrowings Net cash Net borrowings Facility utilisation UK ( m) (123.1) UK (Rm) (1 508) SA (Rm) (94) Group (Rm) (1 602) UK ( m) Cost of debt (%) UK SA (Rm) SA Group Utilised Cash Available CARE DIGNITY TRUTH PARTICIPATION PASSION 30

31 SA gross debt Rm Sep DMTN Preference shares Convertible bond Long-term bank debt Gross debt Applied to fund: SA operating activities Economic interest in UK OpCo debt 582 R1bn 3-year amortising note raised January 2012 Maintained GCR rating (Jan 2012) - A Long-term - A1 Short-term R176m improvement despite increased outlay of R250m in tax, dividends and capex Interest cover improved to 11.8x (Sep 2011: 6.7x) CARE DIGNITY TRUTH PARTICIPATION PASSION 31

32 UK gross debt m Sep OpCo All bank covenants satisfied Transform PropCo PropCo Accrued interest Amortised finance charges (15.8) (12.1) (8.5) All UK debt is non-recourse to SA operations The 4 categories of debt are ring-fenced from each other There is no cross-default across the debt categories 19.5m of debt repaid during H1 Finance leases and other Gross debt CARE DIGNITY TRUTH PARTICIPATION PASSION 32

33 UK debt m PropCo 1 PropCo 2 OpCo Transform Debt Cash (0.4) (3.2) (119.1) (0.4) Net debt Swap liability %d debt at tfixed rates 100% 100% 65% 84% Fixed interest rate 6.3% 7.3% 7.1% 7.6% Interest paid H Debt term Oct 2013 Jan Swap term Reduction in OpCo net tdebt of 46.5m during last 12 months October 2013 debt maturity remains an active work stream Working closely with advisors to fashion a solution Complex debt structure with many parties involved Swaps have seniority (current market value estimated at c 500m*) * Depicts economic value before IFRS adjustment for counterparty valuation adjustment CARE DIGNITY TRUTH PARTICIPATION PASSION 33

34 Working capital Movement SA (Rm) Inventories (60) Trade and other receivables (113) Hospital debtors 25.5 days (Mar 2011: 25.8 days) excluding COID* Marginal timing impact of period close falling over weekend Trade and other payables (1 777) (1 850) 73 Taxation payable (182) (120) (62) R47m STC paid Net working capital (162) UK ( m) Net working capital Strong improvement sustained from September 2011 * COID: Compensation for Occupational Injuries and Diseases CARE DIGNITY TRUTH PARTICIPATION PASSION 34

35 Dividends Distributions determined after having regard for: Enhanced earnings HPFL BEE shareholder requirements SA credit/financial markets New dividend withholding tax of 15% SA leverage ratios De-gearing benefits Working towards sustainable dividend id d cover of x H1 H2 CARE DIGNITY TRUTH PARTICIPATION PASSION 35

36 Guidance 36

37 Guidance 2012 South Africa Estimated revenue growth upper single digit Continued focus on efficiencies and cost reductions Capex ±R1bn United Kingdom Challenging trading conditions expected to continue Continued softness in PMI market Capex < 50m CARE DIGNITY TRUTH PARTICIPATION PASSION 37

38 Disclaimer Netcare has acted in good faith and has made every reasonable effort to ensure the accuracy and completeness of the information contained in this presentation, including all information that may be defined d as 'forward-looking statements'. t t Forward-looking statements may be identified by words such as 'believe', 'anticipate', 'expect', 'plan', 'estimate', 'intend', 'project', 'target', 'predict' and 'hope'. By their nature, forward-looking statements are inherently predictive, speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future, involve known and unknown risks, uncertainties and other facts or factors which may cause the actual results, performance or achievements of the Group, or its sector to be materially different from any results, performance or achievement expressed or implied by such forward-looking statements. Forward-looking statements are not guarantees of future performance and are based on assumptions regarding the Group s present and future business strategies and the environments in which it operates now and in the future. No assurance can be given that forward-looking statements will prove to be correct and undue reliance should not be placed on such statements. Netcare does not undertake to update any forward-looking statements contained in this document and does not assume responsibility for any loss or damage whatsoever and howsoever arising i as a result of the reliance by any party thereon. CARE DIGNITY TRUTH PARTICIPATION PASSION 38

Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011

Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011 Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011 Agenda RICHARD FRIEDLAND GROUP CEO Group overview South Africa United Kingdom KEITH GIBSON GROUP CFO Financial review Guidance

More information

NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION

NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 Group Overview South Africa United Kingdom Financial Review Guidance GROUP OVERVIEW 4 Group A comprehensive network

More information

NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION

NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 PRESENTATION OUTLINE Group Overview South Africa United Kingdom Financial Review Guidance GROUP OVERVIEW 4 Group A comprehensive

More information

Living our values. Netcare Limited Audited Group Results. for the year ended 30 September 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION

Living our values. Netcare Limited Audited Group Results. for the year ended 30 September 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION CARE DIGNITY PARTICIPATION TRUTH PASSION Netcare Limited Audited Group Results for the year ended tember 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION Note regarding forward looking statements The Company

More information

Netcare Limited Interim results presentation For the six months ended 31 March 2008

Netcare Limited Interim results presentation For the six months ended 31 March 2008 1 Netcare Limited Interim results presentation For the six months ended 31 March 2008 Note regarding forward looking statements The Company advises investors that any forward looking statements or projections

More information

care helping for the health of humankind Netcare Limited 2014

care helping for the health of humankind Netcare Limited 2014 helping care for the health of humankind Netcare Limited 2014 AUDITED GROUP RESULTS for the year ended 30 September 2014 Contents Financial highlights 1 Commentary 2 Declaration of final dividend 9 Group

More information

NETCARE LIMITED SUMMARISED AUDITED GROUP RESULTS

NETCARE LIMITED SUMMARISED AUDITED GROUP RESULTS SUMMARISED AUDITED GROUP RESULTS for the year ended 30 September 2017 01 contents02 Commentary 10 Declaration of final dividend 12 Group statement of profit or loss 13 Group statement of other comprehensive

More information

Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015

Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015 www.lifehealthcare.co.za Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015 Operational review André Meyer CEO 2 Highlights Group SA: 3.5%

More information

ANNUAL RESULTS FOR THE YEAR ENDED 31 AUGUST 2017

ANNUAL RESULTS FOR THE YEAR ENDED 31 AUGUST 2017 ANNUAL RESULTS FOR THE YEAR ENDED 31 AUGUST 2017 PRESENTATION OUTLINE Review of the year Financial results Trading performance Outlook Questions 2 REVIEW OF THE YEAR DAVID KNEALE REVIEW OF THE YEAR Strong

More information

DATATEC GROUP UNAUDITED INTERIM RESULTS FOR THE 6 MONTHS ENDED 31 AUGUST 2016

DATATEC GROUP UNAUDITED INTERIM RESULTS FOR THE 6 MONTHS ENDED 31 AUGUST 2016 Technology Distribution Integration & Managed Services Consulting & Research UNAUDITED INTERIM RESULTS FOR THE 6 MONTHS ENDED 31 AUGUST 2016 AGENDA Results summary, market conditions & operational strategy

More information

PRESENTATION OUTLINE. Review of the period Financial results Trading performance Outlook Questions

PRESENTATION OUTLINE. Review of the period Financial results Trading performance Outlook Questions PRESENTATION OUTLINE Review of the period Financial results Trading performance Outlook Questions 2 REVIEW OF THE PERIOD DAVID KNEALE REVIEW OF THE PERIOD Strong health & beauty sales performance Increased

More information

MTN Group Limited Results presentation for the six months ended 30 June 2017

MTN Group Limited Results presentation for the six months ended 30 June 2017 MTN Group Limited Results presentation for the six months ended 30 June 2017 Disclaimer The information contained in this document has not been verified independently. No representation or warranty express

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services November 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015 Genesis HealthCare A Leading National Provider of Post-Acute Services August 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare

More information

Audited Group Results for the year ended 30 September 2013 and cash dividend declaration

Audited Group Results for the year ended 30 September 2013 and cash dividend declaration Life Healthcare Group Holdings Limited Registration number: 2003/002733/06 Income tax number: 9387/307/15/1 ISIN: ZAE000145892 Share code: LHC Audited Group Results for the year ended 30 September 2013

More information

Interim FY 2015 results 6 months ended 31 December February 2015

Interim FY 2015 results 6 months ended 31 December February 2015 Interim FY 2015 results 31 December 2014 18 February 2015 Highlights Solid trading result for 1H FY2015; change in accounting policy for acquisition of healthcare practices First half result highlights

More information

INTERIM RESULTS FOR THE SIX MONTHS ENDED 28 FEBRUARY 2015

INTERIM RESULTS FOR THE SIX MONTHS ENDED 28 FEBRUARY 2015 INTERIM RESULTS FOR THE SIX MONTHS ENDED 28 FEBRUARY 2015 PRESENTATION OUTLINE Review of the period Financial results Trading performance Outlook Questions CLICKS GROUP INTERIM RESULTS 2015 2 REVIEW OF

More information

Capital allocation and enhanced risk management

Capital allocation and enhanced risk management Capital allocation and enhanced risk management MTN Group Limited Ralph Mupita Group CFO UBS conference 26 March 2018 Agenda 1 2 3 Recap on 2017 results Capital allocation Enhanced risk management 2 Recap

More information

Group UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018,

Group UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018, UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018, SCRIP DISTRIBUTION WITH CASH DIVIDEND ALTERNATIVE, FURTHER CAUTIONARY AND TRADING STATEMENT Group LIFE HEALTHCARE UNAUDITED GROUP RESULTS 2018

More information

DATATEC GROUP AUDITED PROVISIONAL RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2018

DATATEC GROUP AUDITED PROVISIONAL RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2018 Technology Distribution Integration & Managed Services Consulting & Research AUDITED PROVISIONAL RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2018 AGENDA Results summary, overview & strategic update Jens Montanana,

More information

Vodacom Group (Proprietary) Limited

Vodacom Group (Proprietary) Limited Driving the future of communication Vodacom Group (Proprietary) Limited For the year ended March 31, 2005 June 6, 2005 Content Alan Knott-Craig Chief Executive Officer Operational highlights Leon Crouse

More information

Interim Results. Six months ended 31 August 2016

Interim Results. Six months ended 31 August 2016 Interim Results Six months ended 31 August 2016 Stefanutti Stocks City A multi-disciplinary construction group (Vision) (Mission) 2 www.stefanuttistocks.com y 2 Agenda Six month overview Operational Overview

More information

Annual Results. 12 months ended 28 February Agenda

Annual Results. 12 months ended 28 February Agenda Annual Results 28 ruary 2015 Bridging y expectations Agenda 2015 2014 2 1 12 month overview Phase 1 of turnaround strategy successfully implemented Closed-out problem contracts Closed non-performing Power

More information

Management s Discussion & Analysis

Management s Discussion & Analysis Management s Discussion & Analysis For the three and six month interim period ended June 30, Medworxx Solutions Inc. 700 121 Richmond St W. Toronto, ON M5H 2K1 This Management s Discussion and Analysis

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services March 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

Unaudited results for the 6 months ended 30 September H Investor Booklet November 2016

Unaudited results for the 6 months ended 30 September H Investor Booklet November 2016 H1 2017 Investor Booklet November 2016 Agenda Overview of Results Financial Review Outlook 2 Overview In the F2016 results presentation (14 July 2016) we said: Dawn board had approved a plan to stop losses

More information

2018 Half Year Results Presentation. 18 September 2018

2018 Half Year Results Presentation. 18 September 2018 2018 Half Year Results Presentation 18 September 2018 Disclaimer These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the Company ), including

More information

Management s Discussion & Analysis

Management s Discussion & Analysis Management s Discussion & Analysis For the three month interim period ended March 31, 2014 Medworxx Solutions Inc. 700-121 Richmond St W. Toronto, ON M5H 2K1 This Management s Discussion and Analysis (

More information

Forward Looking Statements

Forward Looking Statements MLP Care 1Q2018 Presentation 8 May 2018 Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care s future performance and should be considered as

More information

FINANCIAL REVIEW UNDERLYING NON-IFRS FINANCIAL MEASURES 14 MEDICLINIC ANNUAL REPORT 2017 FINANCIAL REVIEW

FINANCIAL REVIEW UNDERLYING NON-IFRS FINANCIAL MEASURES 14 MEDICLINIC ANNUAL REPORT 2017 FINANCIAL REVIEW 14 MEDICLINIC ANNUAL REPORT 2017 FINANCIAL REVIEW FINANCIAL REVIEW UNDERLYING NON-IFRS FINANCIAL MEASURES Jurgens Myburgh Chief Financial Officer The Group uses underlying income statement reporting as

More information

A Leading National Provider of Post-Acute Services

A Leading National Provider of Post-Acute Services A Leading National Provider of Post-Acute Services November 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future

More information

TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017

TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017 TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017 GROUP HIGHLIGHTS 5% Revenue 5% PAT 5% HEPS 35.2c 5% Interim dividend declared 11.0 cents per share Slide 2

More information

12 month overview. Operational Overview. Financial Results. Conclusion

12 month overview. Operational Overview. Financial Results. Conclusion Annual Results 12 months ended 29 ruary 2016 Agenda 12 month overview Operational Overview Financial Results Conclusion 2 1 12 month overview Reasonable financial performance in current market All Business

More information

news FOR IMMEDIATE RELEASE

news FOR IMMEDIATE RELEASE news FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Ed Fishbough 615-344-2688 615-344-2810 HCA Reports First Quarter 2018 Results Nashville, Tenn., May 1, 2018 HCA Healthcare, Inc.

More information

A Leading National Provider of Post-Acute Services

A Leading National Provider of Post-Acute Services A Leading National Provider of Post-Acute Services February 2016 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future

More information

Polypipe Group plc Interim Results

Polypipe Group plc Interim Results Polypipe Group plc Interim Results 6 months to 30 June 2017 Disclaimer The information contained in this presentation has not been independently verified and this presentation contains various forward-looking

More information

news FOR IMMEDIATE RELEASE

news FOR IMMEDIATE RELEASE news FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Ed Fishbough 615-344-2688 615-344-2810 HCA Reports Third Quarter 2018 Results Nashville, Tenn., October 30, 2018 HCA Healthcare,

More information

H1 16 interim results. 22 September 2015

H1 16 interim results. 22 September 2015 H1 16 interim results 22 September 2015 Important notice 2 This presentation may include certain forward-looking statements, beliefs or opinions, including statements with respect to the Company s business,

More information

THE UNIVERSITY OF ILLINOIS HOSPITAL & HEALTH SCIENCES SYSTEM: BOARD OF TRUSTEES MEETING September 12, 2013 UI HOSPITAL DASHBOARD

THE UNIVERSITY OF ILLINOIS HOSPITAL & HEALTH SCIENCES SYSTEM: BOARD OF TRUSTEES MEETING September 12, 2013 UI HOSPITAL DASHBOARD THE UNIVERSITY OF ILLINOIS HOSPITAL & HEALTH SCIENCES SYSTEM: BOARD OF TRUSTEES MEETING September, 2013 UI HOSPITAL DASHBOARD HOSPITAL FINANCIAL PERFORMANCE FOR THE YEAR ENDING 6/30/13 METRIC FY 2013 Unaudited

More information

Analyst conference Nine-months 2018 results

Analyst conference Nine-months 2018 results Analyst conference Nine-months 2018 results Kuehne + Nagel International AG 18 October 2018 (CET 14.00) Schindellegi, Switzerland Forward-looking statements This presentation contains forward-looking statements.

More information

ANALYST PRESENTATION FOR THE YEAR ENDED 31 MARCH 2012

ANALYST PRESENTATION FOR THE YEAR ENDED 31 MARCH 2012 ANALYST PRESENTATION FOR THE YEAR ENDED 31 MARCH 2012 1 TFG ANALYST PRESENTATION MARCH 2012 AGENDA Overview of the economy and retail environment Review of the year Financial review Divisional review Financial

More information

Interim Results March Paul Stuiver - CEO

Interim Results March Paul Stuiver - CEO Interim Results March 2012 Paul Stuiver - CEO 1 Agenda Context Financial Overview Divisional Overview Outlook Questions 2 Context For the six months from October 2011 to March 2012 The positive trend in

More information

2017 FULL YEAR RESULTS PRESENTATION

2017 FULL YEAR RESULTS PRESENTATION 2017 FULL YEAR RESULTS PRESENTATION MEDICLINIC RESULTS DISCLAIMER This presentation contains certain forward-looking statements relating to the financial condition, the regulatory environment in which

More information

OVERVIEW. Comparable HEPS up 4.5% Restaurant sales up 10.4% Comparable profit before tax up 5.0% Interim dividend per share up 6.

OVERVIEW. Comparable HEPS up 4.5% Restaurant sales up 10.4% Comparable profit before tax up 5.0% Interim dividend per share up 6. OVERVIEW Restaurant sales up 10.4% (from continuing operations) Comparable HEPS up 4.5% (from continuing operations) Comparable profit before tax up 5.0% (from continuing operations) Interim dividend per

More information

Looking to the medium term

Looking to the medium term Looking to the medium term Issued: 4 September 2013 Legal notice This presentation has been prepared to inform investors and prospective investors in the secondary markets about the Group and does not

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services May 2017 2017 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of

More information

FY 2015 Results Presentation. 19 January 2016

FY 2015 Results Presentation. 19 January 2016 FY 2015 Results Presentation 19 January 2016 Disclaimer THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL SECURITIES IN THE UNITED STATES OF AMERICA OR IN ANY OTHER JURISDICTION.

More information

Bactiguard. Q1 presentation May 4, 2017

Bactiguard. Q1 presentation May 4, 2017 1 Bactiguard Q1 presentation May 4, 2017 Bactiguard sponsors the Global Sepsis Alliance 2 The Global Sepsis Alliance a non-profit charity with the aim to raise awareness of sepsis worldwide and reduce

More information

FINANCIAL REVIEW INTRODUCTION. Jurgens Myburgh Chief Financial Officer

FINANCIAL REVIEW INTRODUCTION. Jurgens Myburgh Chief Financial Officer FINANCIAL REVIEW OUR COMMITMENT TO SHAREHOLDER VALUE IS MEASURED USING RETURNS ON INVESTED CAPITAL, THEREBY FOCUSING STRATEGIC DELIBERATIONS ON WAYS TO IMPROVE RETURNS ON THE GROUP S INVESTED ASSET BASE.

More information

Highlights of the Group s performance include:

Highlights of the Group s performance include: MEDIA RELEASE 21 November 2017 LIFE HEALTHCARE GROUP POSTS SOLID RESULTS POST ALLIANCE MEDICAL ACQUISITION Johannesburg, 21 November 2017: Life Healthcare Group Holdings Limited (JSE: LHC), one of South

More information

Innovating for the healthcare needs of today and tomorrow. Q3 presentation 12 November 2015

Innovating for the healthcare needs of today and tomorrow. Q3 presentation 12 November 2015 1 Innovating for the healthcare needs of today and tomorrow Q3 presentation 12 November 2015 Antibiotic resistance and healthcare associated infections at the top of the political agenda 2 Global consumption

More information

2010 Annual Results. November 2010

2010 Annual Results. November 2010 2010 Annual Results November 2010 1 Agenda Highlights Group results Operational review Strategic Update 2 Highlights Operating profit up 126% Trading margin improved from 5.8% to 8.3% Sale/closure of under-performers

More information

enx Group Limited results presentation

enx Group Limited results presentation enx Group Limited results presentation for the year ended 31 August 2018 Disclaimer Certain statements in this presentation regarding enx s business operations may constitute forward looking statements.

More information

RESULTS PRESENTATION

RESULTS PRESENTATION THE FOSCHINI GROUP LIMITED RESULTS PRESENTATION FOR THE 6 MONTHS ENDED 30 SEPTEMBER RESULTS PRESENTATION FOR THE HALFYEAR ENDED 30 SEPTEMBER AGENDA Economy and retail environment Doug Murray Business

More information

THE FOSCHINI GROUP LIMITED RESULTS PRESENTATION

THE FOSCHINI GROUP LIMITED RESULTS PRESENTATION THE FOSCHINI LIMITED RESULTS PRESENTATION FOR THE HALF-YEAR ENDED 30 SEPTEMBER 2017 RESULTS PRESENTATION FOR THE HALF-YEAR ENDED 30 SEPTEMBER 2017 AGENDA Doug Murray Chief Executive Officer Anthony Thunstrӧm

More information

Interim Results. 6 months to 30 September November 2010 The Lincoln Centre, London

Interim Results. 6 months to 30 September November 2010 The Lincoln Centre, London Interim Results 6 months to 30 September 2010 23 November 2010 The Lincoln Centre, London Disclaimers For the purposes of the following disclaimers, references to this "document" shall be deemed to include

More information

MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION

MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION J.P. MORGAN HEALTHCARE CONFERENCE 10 JANUARY 2018 DANIE MEINTJES CEO MEDICLINIC INTERNATIONAL PLC MEDICLINIC RESULTS DISCLAIMER This presentation contains

More information

Barloworld Limited. Reviewed interim results to 31 March May 15, 2006

Barloworld Limited. Reviewed interim results to 31 March May 15, 2006 Barloworld Limited Reviewed interim results to 31 March 2006 May 15, 2006 BARLOWORLD IS A DIVERSIFIED INDUSTRIAL COMPANY Over 26 000 people in 31 countries Barloworld s way of doing business - market-leading

More information

NETCARE LIMITED 2017

NETCARE LIMITED 2017 NETCARE LIMITED ANNUAL FINANCIAL STATEMENTS 2017 contents ANNUAL FINANCIAL STATEMENTS 02 Directors' responsibility and approval 02 Certificate by the Company Secretary 03 Directors' report 10 Audit Committee

More information

EVRY ASA Q PRESENTATION CEO BJÖRN IVROTH CFO HENRIK SCHIBLER

EVRY ASA Q PRESENTATION CEO BJÖRN IVROTH CFO HENRIK SCHIBLER 1 EVRY ASA Q3 2018 PRESENTATION CEO BJÖRN IVROTH CFO HENRIK SCHIBLER Agenda Group highlights Business update Financial highlights Business area performance Concluding remarks Q&A 2 Group highlights Q3

More information

FULL YEAR 2018 PRESS CONFERENCE FEBRUARY 20, Rice Powell CEO. Copyright

FULL YEAR 2018 PRESS CONFERENCE FEBRUARY 20, Rice Powell CEO. Copyright FULL YEAR 2018 PRESS CONFERENCE FEBRUARY 20, 2019 Rice Powell CEO Copyright Safe harbor statement: This presentation includes certain forward-looking statements within the meaning of Section 27A of the

More information

CABOT CREDIT MANAGEMENT Financial Results. For the nine months ended 30 September 2018

CABOT CREDIT MANAGEMENT Financial Results. For the nine months ended 30 September 2018 CABOT CREDIT MANAGEMENT Financial Results For the nine months ended 30 September 2018 8 November 2018 DISCLAIMER This presentation has been prepared by Cabot Credit Management ( the Company ) solely for

More information

Responsible investment in growth

Responsible investment in growth Responsible investment in growth Issued: 1 March 2016 Legal notice This presentation has been prepared to inform investors and prospective investors in the secondary markets about the Group and does not

More information

Earnings Presentation 2nd Quarter 2017

Earnings Presentation 2nd Quarter 2017 Earnings Presentation 2nd Quarter 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section

More information

SEHK: Interim Results. 12 August 2009

SEHK: Interim Results. 12 August 2009 SEHK: 215 29 Interim Results 12 August 29 Disclaimer These materials have been prepared by Hutchison Telecommunications Hong Kong Holdings Limited (HTHKH) solely for use at this presentation and have not

More information

Investing for the future: Spire

Investing for the future: Spire Investing for the future: Spire Healthcare Aslam Dalvi - Associate Portfolio Manager The UK public healthcare system has come under increasing pressure in recent times. An ageing population coupled with

More information

Hero Acquisitions Limited (subsidiary of HSS Hire Group plc) 9M FY15 Results

Hero Acquisitions Limited (subsidiary of HSS Hire Group plc) 9M FY15 Results Hero Acquisitions Limited (subsidiary of HSS Hire Group plc) 9M FY5 Results November 205 Agenda John Gill, CEO: Introduction Steve Trowbridge, CFO: 9M Results John Gill, CEO: Summary Q&A Introduction 0.7%

More information

Unaudited results. for the six months ended 30 November ISIN: ZAE Share code: ARH. ARB Holdings Limited

Unaudited results. for the six months ended 30 November ISIN: ZAE Share code: ARH. ARB Holdings Limited www.arbhold.co.za ARB Holdings Limited Registration number: 1986/002975/06 Share code: ARH ISIN: ZAE000109435 ( ARB or the Company or the Group ) for the six months ended 30 November 2016 Unaudited results

More information

AAFRICAN AFRICAN OXYGEN LIMITED Results 40. th annual results since listing

AAFRICAN AFRICAN OXYGEN LIMITED Results 40. th annual results since listing AAFRICAN AFRICAN OXYGEN LIMITED 2004 Results 40 th annual results since listing 1 AAFROX Presenters Rick Hogben Cor van Zyl CE African Oxygen Limited Financial Director, African Oxygen Limited Panel Mike

More information

OVERVIEW Group highlights. The Maslow Hotel

OVERVIEW Group highlights. The Maslow Hotel OVERVIEW Group highlights The Maslow Hotel 2 Key indicators R5 407m R1 489m 334 cps 90 cps GROUP REVENUE GROUP EBITDA ADJ DILUTED HEPS DPS +4% (5%) (18%) (18%) 3 Kalahari Sands Operating environment Pressure

More information

Period overview Operational Overview Financial Results Conclusion

Period overview Operational Overview Financial Results Conclusion Interim Results Six months ended 31 ust 2015 Bridging y expectations Agenda Period overview Operational Overview Financial Results Conclusion Bridging y expectations 2 1 Six month overview Satisfactory

More information

5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director

5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director 5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director AGENDA About Ramsay Health Care The Reason for Ramsay s Success December 07 Half Year Results

More information

SABMiller plc. Full year results Twelve months ended 31 March Graham Mackay, Chief Executive Jamie Wilson, Chief Financial Officer.

SABMiller plc. Full year results Twelve months ended 31 March Graham Mackay, Chief Executive Jamie Wilson, Chief Financial Officer. SABMiller plc Full year results Twelve months ended 31 March 2012 Graham Mackay, Chief Executive Jamie Wilson, Chief Financial Officer 24 May 2012 Forward looking statements This presentation includes

More information

FY16 YEAR END RESULTS 5 APRIL 2016

FY16 YEAR END RESULTS 5 APRIL 2016 FY16 YEAR END RESULTS 5 APRIL 2016 DEFINITIONS AND IMPORTANT NOTICE The following definitions apply throughout Trading EBITDA (earnings before interest, tax, depreciation and amortisation): excludes exceptional

More information

FINANCIAL RESULTS PRESENTATION H1FY18

FINANCIAL RESULTS PRESENTATION H1FY18 Virtus Health (ASX:VRT) FINANCIAL RESULTS PRESENTATION H1FY18 Tuesday 20 th February, 2018 9.15am AEDT DISCLAIMER The material in this presentation has been prepared by Virtus Health Limited ABN 80 129

More information

FY2019 Interim results presentation

FY2019 Interim results presentation EXPLORE OUR WORLD Established 1975 I Listed JSE limited 1987 ADCORP IS A WORKPLACE SOLUTIONS COMPANY Presented by Innocent Dutiro Chief Executive Officer Cheryl Jane CJ Kujenga Chief Financial Officer

More information

LIFE HEALTHCARE OUR MISSION IS TO IMPROVE THE LIVES OF PEOPLE THROUGH THE DELIVERY OF HIGH QUALITY COST EFFECTIVE CARE

LIFE HEALTHCARE OUR MISSION IS TO IMPROVE THE LIVES OF PEOPLE THROUGH THE DELIVERY OF HIGH QUALITY COST EFFECTIVE CARE LIFE HEALTHCARE AUDITED SUMMARISED CONSOLIDATED RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2017, DECLARATION OF SCRIP DISTRIBUTION WITH CASH DIVIDEND ALTERNATIVE AND TRADING STATEMENT. Life Well-being and

More information

Dr. Anna Mokgokong Chairperson

Dr. Anna Mokgokong Chairperson Dr. Anna Mokgokong Chairperson To relentlessly innovate a new integrated model of sustainable healthcare that measurably improves access to quality care Empowering greater access to sustainable quality

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services September 2017 2017 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007

Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007 Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007 AGENDA Ramsay Financial Performance Pre Capio UK ( Ramsay UK ) Ramsay Financial Performance Including Ramsay UK Operational

More information

Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier

Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier AGENDA 2 Executive Summary Why the UK Hospital Sector? Capio UK Business Overview Transaction Overview Financials Compelling Proposition

More information

Financial Results - Year Ended 31 March 2018 Investor Presentation

Financial Results - Year Ended 31 March 2018 Investor Presentation Financial Results - Year Ended 31 March 2018 Investor Presentation Agenda Overview of FY18 Page 4 FY18 Financial Results: Segment Results Centre Metrics Impairments Balance sheet and funding Driving Performance

More information

Preliminary Results. Year ended 31 March May 2010 The Lincoln Centre, London

Preliminary Results. Year ended 31 March May 2010 The Lincoln Centre, London Preliminary Results Year ended 31 March 2010 28 May 2010 The Lincoln Centre, London Sir John Egan Chairman Mike McKeon Finance Director Highlights 2008/09 2009/10 Change m m % Group Turnover 1,642 1,704

More information

2011 Interim Results. Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer

2011 Interim Results. Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer 2011 Interim Results Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer Emeco 2011 Interim Results Overview Financials Strategy & Outlook Questions Appendices

More information

INTERIM RESULTS PRESENTATION SIX MONTHS TO 30 JUNE 2018

INTERIM RESULTS PRESENTATION SIX MONTHS TO 30 JUNE 2018 INTERIM RESULTS PRESENTATION SIX MONTHS TO 30 JUNE 2018 DISCLAIMER The information contained in this presentation has not been independently verified and this presentation contains various forward-looking

More information

1. Income Statement January - March (unaudited)

1. Income Statement January - March (unaudited) 1. Income Statement January - March (unaudited) CHF million 2008 2007 Variance Excl. Forex Invoiced turnover 5'310 4'870 9.0% 12.6% Customs duties and taxes (902) (936) Net invoiced turnover 4'408 3'934

More information

Earnings Presentation 4th Quarter, 2017

Earnings Presentation 4th Quarter, 2017 Earnings Presentation 4th Quarter, 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section

More information

SUMMARISED CONSOLIDATED RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2018, AND CASH DIVIDEND DECLARATION. Group

SUMMARISED CONSOLIDATED RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2018, AND CASH DIVIDEND DECLARATION. Group SUMMARISED CONSOLIDATED RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2018, AND CASH DIVIDEND DECLARATION Group LIFE HEALTHCARE SUMMARISED CONSOLIDATED RESULTS 2018 Highlights Revenue +12.9% to R23.5 billion

More information

UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2013

UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2013 UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2013 AGENDA AGENDA GROUP OVERVIEW FINANCIAL REVIEW DIVISIONAL REVIEW OUTLOOK QUESTIONS 2 3 GROUP OVERVIEW GROUP STRUCTURE INDUSTRIAL EQUIPMENT

More information

HomeChoice International PLC summarised group financial statements for the year ended 31 December 2016 and cash dividend declaration

HomeChoice International PLC summarised group financial statements for the year ended 31 December 2016 and cash dividend declaration HomeChoice International PLC summarised group financial statements for the year ended 31 December and cash dividend declaration HomeChoice International PLC 1 Commentary Group highlights sales up 25.1

More information

SIX MONTHS ENDED 30 SEPTEMBER 2018

SIX MONTHS ENDED 30 SEPTEMBER 2018 PRESENTATION TUESDAY, 20 NOVEMBER 2018 SIX MONTHS ENDED 30 SEPTEMBER 2018 CONTENTS PRESENTED BY Neil Birch Chief Executive Officer Harry Todd Chief Financial Officer 2 EXECUTIVE OVERVIEW 3 RESULTS SUMMARY

More information

Kuehne + Nagel International AG Analyst Conference Full-year 2016 results. March 1, 2017 (CET 14.00) Zurich, Switzerland

Kuehne + Nagel International AG Analyst Conference Full-year 2016 results. March 1, 2017 (CET 14.00) Zurich, Switzerland Kuehne + Nagel International AG Analyst Conference Full-year 2016 results March 1, 2017 (CET 14.00) Zurich, Switzerland Forward-looking statements This presentation contains forward-looking statements.

More information

PRELIMINARY RESULTS PRESENTATION YEAR ENDED 31 DECEMBER 2017

PRELIMINARY RESULTS PRESENTATION YEAR ENDED 31 DECEMBER 2017 PRELIMINARY RESULTS PRESENTATION YEAR ENDED 31 DECEMBER 2017 DISCLAIMER The information contained in this presentation has not been independently verified and this presentation contains various forward-looking

More information

PRESENTATION TO INVESTORS FOR THE YEAR ENDED 30 SEPTEMBER 2015

PRESENTATION TO INVESTORS FOR THE YEAR ENDED 30 SEPTEMBER 2015 PRESENTATION TO INVESTORS FOR THE YEAR ENDED 30 SEPTEMBER 2015 AGENDA GROUP OVERVIEW Alan Dickson, CEO FINANCIAL OVERVIEW Nick Thomson, CFO SEGMENTAL DISCUSSIONS ICT Mark Taylor Applied electronics Peter

More information

Facility State National

Facility State National Percentage Summary Report Page 1 of 5 Data As Of: 09/12/2018 Total Facility State National 31.416666666667 39.359722222222 38.095746590093 Unweighted Domain Weighting Weighted Domain Clinical Care Domain

More information

THE FOSCHINI GROUP LIMITED RESULTS PRESENTATION

THE FOSCHINI GROUP LIMITED RESULTS PRESENTATION THE FOSCHINI GROUP LIMITED RESULTS PRESENTATION RESULTS PRESENTATION AGENDA Economy and retail environment Doug Murray Business overview Doug Murray Review of the year Doug Murray Financial review Anthony

More information

RESULTS PRESENTATION FOR THE YEAR ENDED 30 JUNE

RESULTS PRESENTATION FOR THE YEAR ENDED 30 JUNE RESULTS PRESENTATION FOR THE YEAR ENDED 30 JUNE 2016 DISCLAIMER Certain statements in this document may constitute forward looking statements. Such forward looking statements reflect the company s beliefs

More information

Earnings Presentation 3rd Quarter, 2018

Earnings Presentation 3rd Quarter, 2018 Earnings Presentation 3rd Quarter, 2018 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section

More information

Interim report for Bactiguard Holding AB (publ) Corporate registration number

Interim report for Bactiguard Holding AB (publ) Corporate registration number Interim report for Bactiguard Holding AB (publ) Corporate registration number 556822-1187 First quarter (January-March 2015) Revenues amounted to SEK 28.8 (34.5) million EBITDA amounted to SEK -26.8 (9.8)

More information

INTERIM RESULTS PRESENTATION FOR THE SIX-MONTH PERIOD ENDED 30 JUNE 2017

INTERIM RESULTS PRESENTATION FOR THE SIX-MONTH PERIOD ENDED 30 JUNE 2017 INTERIM RESULTS PRESENTATION FOR THE SIX-MONTH PERIOD ENDED 30 JUNE 2017 DISCLAIMER Certain statements in this document may constitute forward looking statements. Such forward looking statements reflect

More information